5 completed, 3 unknown, 1 recruiting, 1 terminated. 4 Phase 4, 3 Phase 1, 2 Phase 2, 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 2, Completed 1, Terminated 1 |
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Withdrawn 1 |
Follow Ciclopirox: new trials by email Literature Review of Ciclopirox trials Research Report on Ciclopirox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP ATL-001 (Ciclopirox oral solution) - Congenital Erythropoietic Porphyria (CEP) | Phase 1 / Phase 2 | Recruiting | Atlas Molecular Pharma | 6 | 2026-01-29 | 2026-03-24 |
| Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers Ciclopirox Olamine Oral, Placebo - Adverse Effect of Drugs and Medicaments in Therapeutic Use | Phase 1 | Completed | Atlas Molecular Pharma | 42 | 2023-03-31 | 2024-07-24 |
| The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis CELEXT07, Penlac, vehicle solution - Onychomycosis | Phase 2 | Unknown | 9305-9954 Quebec Inc | 120 | 2016-11-01 | 2017-04-26 |
| Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO) MOB015B, Ciclopirox 80 mg/g - Distal Subungual Onychomycosis | Phase 3 | Completed | Moberg Pharma AB | 452 | 2016-09-01 | 2020-10-06 |
| Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis Protopic (R), Mycoster (R) - Severe Seborrheic Dermatitis | Phase 3 | Completed | University Hospital, Rouen | 120 | 2014-01-01 | 2018-05-29 |
| Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea oral isotretinoin, salicylic acid and ciclopirox olamine - Seborrhea, Seborrheic Dermatitis | Phase 4 | Unknown | Federal University of São Paulo | 50 | 2011-10-01 | 2011-10-12 |
| Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy Ciclopirox Olamine - Hematologic Malignancy, Acute Lymphocytic Leukemia | Phase 1 | Completed | University Health Network, Toronto | 20 | 2009-10-01 | 2015-06-22 |
| Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis Amorolfine (Antifungal), RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal) - Onychomycosis | Phase 4 | Unknown | Pierre Fabre Dermo Cosmetique | 260 | 2009-08-01 | 2009-11-17 |
| Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children ciclopirox - Dermatomycoses | Phase 4 | Terminated | Ferrer Internacional S.A. | 21 | 2008-10-01 | 2012-07-20 |
| Topical Penlac Nail Lacquer for Onychomycosis in Children Ciclopirox, Placebo - Onychomycosis | Phase 4 | Completed | Rady Children's Hospital, San Diego | 40 | 2002-03-01 | 2011-08-18 |
| Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox. Ciclopirox - Vulvar Cancer | Not applicable | Withdrawn | University of Medicine and Dentistry of New Jersey | 2013-09-06 |
Onychomycosis (3) · Dermatitis, Seborrheic (2) · Dermatomycoses (2) · Anemia, Refractory, with Excess of Blasts (1) · Blast Crisis (1) · Candidiasis (1) · Cellulitis (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Infections (1) · Leukemia, B-Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Mycoses (1)
Atlas Molecular Pharma (2) · 9305-9954 Quebec Inc (1) · Federal University of São Paulo (1) · Ferrer Internacional S.A. (1) · Moberg Pharma AB (1) · Pierre Fabre Dermo Cosmetique (1) · Rady Children's Hospital, San Diego (1) · University Health Network, Toronto (1) · University Hospital, Rouen (1) · University of Medicine and Dentistry of New Jersey (1)
United States (4) · Canada (2) · France (2) · Brazil (1) · Germany (1) · Poland (1) · United Kingdom (1)
Bernadette Cracchiolo, MD, MPH (1) · Edileia Bagatin, PhD (1) · Guy Chamberland, M.Sc., Ph.D. (1) · Jose C Moreno, Prof, PhD (1) · Mark Minden, MD (1) · Sheila F Friedlander, MD (1)
2008 (1)